Edwards Lifesciences Corp. insider trading
In the last twelve months insiders at Edwards Lifesciences Corp. filed 35 open-market sales worth $18.5 million and 0 open-market purchases, on Form 4 with the SEC. The latest: Lippis Daniel J., CVP, TAVR, sold 619 shares at $87.51 on 11 September 2026, filed 11 September 2026.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 11 September 2026 | Lippis Daniel J. | CVP, TAVR | Sale | 619 | $87.51 | $54,169 | Form 4 |
| 31 August 2026 | Dahl Andrew M. | SVP, Corporate Controller | Sale | 544 | $91.06 | $49,534 | Form 4 |
| 28 August 2026 | Bruls Annette | CVP, EMEACLA | Sale | 2,644 | $89.98 | $237,907 | Form 4 |
| 26 August 2026 | Chopra Daveen | CVP, TMTT, Surgical & IHFM | Sale | 1,154 | $91.76 | $105,893 | Form 4 |
| 26 August 2026 | Chopra Daveen | CVP, TMTT, Surgical & IHFM | Sale | 30,646 | $90.99 | $2.8 million | Form 4 |
| 26 August 2026 | Markowitz Wayne | CVP, JAPAC | Sale | 1,240 | $91.47 | $113,417 | Form 4 |
| 11 August 2026 | Lippis Daniel J. | CVP, TAVR | Sale | 619 | $92.03 | $56,967 | Form 4 |
| 30 July 2026 | Markowitz Wayne | CVP, JAPAC | Sale | 146 | $86.03 | $12,588 | Form 4 |
| 28 July 2026 | Markowitz Wayne | CVP, JAPAC | Sale | 9,628 | $85.06 | $818,958 | Form 4 |
| 27 July 2026 | Zovighian Bernard J | CEO | Sale | 2,921 | $83.93 | $245,134 | Form 4 |
| 10 July 2026 | Lippis Daniel J. | CVP, TAVR | Sale | 619 | $91.70 | $56,762 | Form 4 |
| 30 June 2026 | Lippis Daniel J. | CVP, TAVR | Sale | 619 | $91.40 | $56,577 | Form 4 |
| 17 June 2026 | Zovighian Bernard J | CEO | Sale | 523 | $87.92 | $45,982 | Form 4 |
| 29 May 2026 | Dahl Andrew M. | SVP, Corporate Controller | Sale | 568 | $86.08 | $48,853 | Form 4 |
| 27 May 2026 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Sale | 23,145 | $86.42 | $2.0 million | Form 4 |
| 22 May 2026 | Chopra Daveen | CVP, TMTT & Surgical | Sale | 1,500 | $84.60 | $126,905 | Form 4 |
| 18 May 2026 | Lippis Daniel J. | CVP, TAVR | Sale | 620 | $81.14 | $50,307 | Form 4 |
| 15 May 2026 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Sale | 9,968 | $82.07 | $818,106 | Form 4 |
| 15 May 2026 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Sale | 8,000 | $81.82 | $654,573 | Form 4 |
| 12 May 2026 | Zovighian Bernard J | CEO | Sale | 845 | $78.40 | $66,250 | Form 4 |
| 12 May 2026 | Zovighian Bernard J | CEO | Sale | 35,506 | $77.92 | $2.8 million | Form 4 |
| 11 May 2026 | Markowitz Wayne | CVP, JAPAC | Sale | 593 | $79.73 | $47,280 | Form 4 |
| 4 May 2026 | Lippis Daniel J. | CVP, TAVR | Sale | 1,019 | $83.98 | $85,576 | Form 4 |
| 1 May 2026 | Lippis Daniel J. | CVP, TAVR | Sale | 19 | $83.99 | $1,596 | Form 4 |
| 1 May 2026 | Lippis Daniel J. | CVP, TAVR | Sale | 1,000 | $82.99 | $82,989 | Form 4 |
| 9 April 2026 | Ullem Scott B. | CVP, Chief Financial Officer | Sale | 4,676 | $80.50 | $376,401 | Form 4 |
| 9 April 2026 | Ullem Scott B. | CVP, Chief Financial Officer | Sale | 8,324 | $79.79 | $664,144 | Form 4 |
| 6 April 2026 | Lippis Daniel J. | CVP, TAVR | Sale | 1,019 | $80.98 | $82,523 | Form 4 |
| 2 April 2026 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Sale | 4,676 | $80.59 | $376,846 | Form 4 |
| 2 April 2026 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Sale | 18,004 | $80.05 | $1.4 million | Form 4 |
| 11 March 2026 | Ullem Scott B. | CVP, Chief Financial Officer | Sale | 5,099 | $84.46 | $430,668 | Form 4 |
| 11 March 2026 | Ullem Scott B. | CVP, Chief Financial Officer | Sale | 7,901 | $85.21 | $673,228 | Form 4 |
| 11 March 2026 | Lippis Daniel J. | CVP, TAVR | Sale | 1,019 | $85.38 | $87,004 | Form 4 |
| 2 March 2026 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Sale | 11,340 | $85.93 | $974,430 | Form 4 |
| 25 February 2026 | Bobo Donald E Jr | CVP,Strategy/Corp Development | Sale | 24,000 | $83.84 | $2.0 million | Form 4 |
Open-market purchases (code P) and sales (code S) only. Option exercises, grants, tax withholding and gifts are not shown. A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for Edwards Lifesciences Corp.: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.